December 2006- Volume 2, Issue 12

December 2006

In this Issue

Research & Development

Gene therapy for epilepsy

Gene therapy for epilepsy

Researchers significantly reduce the development of epileptic seizures in rats.

Marcadia, IU in metabolic research deal

Marcadia, IU in metabolic research deal

Deal gives the start-up company the rights to develop and market drug candidates.

e-Therapeutics takes the road to Rio

e-Therapeutics takes the road to Rio

Company forms discovery partnerships with two Brazilian groups

Informatics

Raiders of the lost chemistry

Raiders of the lost chemistry

Database to plumb depths of academic research.

Gene Network Sciences receives SBIR

Gene Network Sciences receives SBIR

Company to continue development of its VisualHeart modeling software for predicting the cardiac effects of medications.

Making a bid for grid

Making a bid for grid

Altair and SciTegic team up to improve efficiencies in drug discovery work.

Broadband engine speeds discovery

Broadband engine speeds discovery

Mercury collaborates with Boston University to boost processing time.

Editor's Focus

Peace: A nod to things pharma does right

Peace: A nod to things pharma does right

As another year draws to a close, I find myself growing weary of the hell-fire and damnation—if only for one issue (so be warned). And so, my gentle readers, I have come to praise pharma, not to bury it.
Protein Therapy vs. Gene Therapy

Protein Therapy vs. Gene Therapy

Protein Therapy vs. Gene Therapy

Proteins are the most important molecules inside every living cell, tissue, organ—and inside the human body.

Automation & Instrumentation

Waters, Advion to collaborate

Waters, Advion to collaborate

Combination of ion mobility separation and chip-based sample introduction a win-win

Q&A: Marc Casper, EVP, Thermo Fisher Scientific

Q&A: Marc Casper, EVP, Thermo Fisher Scientific

Merger created a life sciences distribution, tools and reagents behemoth.

Faster than a speeding toxicity

Faster than a speeding toxicity

Iconix and Affymetrix pair up to improve speed of toxicogenomics

Gamma Medica acquires AMI

Gamma Medica acquires AMI

Merger could mean the emergence of PET-MRI systems.

Ambit, Cephalon sign screening agreement

Ambit, Cephalon sign screening agreement

Companies to tackle kinases, key molecules in many disease pathways.

Genomics & Proteomics

Illumina, Solexa to merge

Illumina, Solexa to merge

$600 million deal creates broad-based genetic analysis company.

Applied Bio, Eagle to collaborate

Applied Bio, Eagle to collaborate

Companies to co-develop detection device for protein and DNA analysis.

Structure and function

Structure and function

NIH initiative seeks to speed up the process of determining protein structures
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue